CG Oncology Inc.
$74.34
-4.67 (-5.91%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +1.8%
- 3 Months
- +19.3%
- YTD
- +79.0%
- 1 Year
- +180.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 57.4%
- Largest decline max drawdown, since Aug 2025
- -27.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 2.08
Own CGON?
See how CGON contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.